After NF-κB signaling is activated, RELA binds to GC-rich exon genes, recruits DDX17, and utilizes the helicase activity of DDX17 to regulate CD44 alternative splicing to promote the progression of ATLL (34). The gene discussed is DDX17; the disease is adult T-cell leukemia/lymphoma.